Validation of a Kinetic Model of Erlotinib
Latest Information Update: 05 Nov 2021
At a glance
- Drugs Erlotinib (Primary)
- Indications Non-small cell lung cancer
- Focus Pharmacokinetics
- 29 Sep 2016 New trial record
Latest Information Update: 05 Nov 2021